Macular blood flow changes in dysthyroid optic neuropathy after high-dose intravenous pulse methylprednisolone (IVMP)

被引:1
|
作者
Fan, Shu-xian [1 ]
Liang, Jia-qi [1 ]
Wang, Jing [1 ]
Zhou, Chong [1 ]
Zhou, Shi-you [2 ]
Wang, Mei [1 ]
Zeng, Peng [1 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ophthalmol, 107 West Yanjiang Rd, Guangzhou 510120, Peoples R China
[2] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Peoples R China
关键词
Dysthyroid optic neuropathy; Methylprednisolone; Macula; Vessel densities; Optical coherence tomography angiography; GRAVES ORBITOPATHY EUGOGO; EUROPEAN GROUP; MANAGEMENT; GUIDELINES; PERFUSION; DENSITY;
D O I
10.1016/j.pdpdt.2023.103935
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the changes in macular vessel density (VD) of the superficial layer of retina (SLR) and deep layer of retina (DLR) in dysthyroid optic neuropathy (DON) after high-dose intravenous pulse methyl-prednisolone (IVMP). Materials and Methods: Eighteen DON patients (29 eyes) who completed high-dose IVMP and 16 healthy in-dividuals (32 eyes) were enrolled in this study. Optical coherence tomography angiography (OCTA) image analysis and comprehensive ophthalmic examinations were performed, including the SLR macular whole-image VD (SLR-mwiVD) and DLR-mwiVD, best-corrected visual acuity (BCVA), the mean deviation of visual field (VF-MD), pattern standard deviation of visual field (VF-PSD) and the other parameters.Results: The SLR-mwiVD (41.39 +/- 4.71 vs. 48.13 +/- 3.68, p < 0.001) and DLR-mwiVD (40.77 +/- 5.85 vs. 49.14 +/- 7.02, p < 0.001) were decreased in DON compared to control eyes. After IVMP, visual function parameters were improved, and SLR-mwiVD (49.41 +/- 3.18, p < 0.001) and DLR-mwiVD (50.41 +/- 4.04, p < 0.001) were increased in the DON group compared to pretreatment. The increased SLR-mwiVD and DLR-mwiVD were significantly correlated with improvements in BCVA (Log MAR: from 0.62 +/- 0.49 to-0.01 +/- 0.03, p < 0.001), VF-MD (from - 6.89 +/- 2.89 dB to - 1.75 +/- 1.29 dB, p < 0.001) and VF-PSD (from 4.38 +/- 2.52 dB to 2.32 +/- 1.64 dB, p < 0.001).Conclusion: The increase in macular VD was significantly correlated with the improvement in visual function in DON after IVMP. Macular VD changes on OCTA may be a useful indicator for the response in DON after IVMP.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Therapeutic Outcomes of High-Dose Intravenous Steroids in the Treatment of Dysthyroid Optic Neuropathy
    Curro, Nicola
    Covelli, Danila
    Vannucchi, Guia
    Campi, Irene
    Pirola, Giacinta
    Simonetta, Simona
    Dazzi, Davide
    Guastella, Claudio
    Pignataro, Lorenzo
    Beck-Peccoz, Paolo
    Ratiglia, Roberto
    Salvi, Mario
    THYROID, 2014, 24 (05) : 897 - 905
  • [2] Visual recovery after oral high-dose methylprednisolone in acute inflammatory optic neuropathy
    Boureaux, Elodie
    Laurent, Charlotte
    Rodriguez, Thomas
    Le Page, Emanuelle
    Mouriaux, Frederic
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (12) : 3979 - 3985
  • [3] Autoinimune hepatitis after high-dose intravenous methylprednisolone pulse in RR-MS
    Reuss, Reinhard
    Retzlaff, Kerstin
    Vogel, Sabine
    Franke, Folker Ernst
    Oschmann, Patrick
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2007, 2 (03): : 356 - 359
  • [4] ACUTE ARTHRALGIA AFTER HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE
    BAILEY, RR
    ARMOUR, P
    LANCET, 1974, 2 (7887): : 1014 - 1014
  • [5] BRADYCARDIA AFTER HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE THERAPY
    TVEDE, N
    NIELSEN, LP
    ANDERSEN, V
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1986, 15 (03) : 302 - 304
  • [6] ACUTE ARTHRALGIA AFTER HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE
    GOLDMAN, JA
    LANCET, 1974, 2 (7892): : 1333 - 1333
  • [7] Pseudophakic cystoid macular edema treated with high-dose intravenous methylprednisolone
    Abe, T
    Hayasaka, S
    Nagaki, Y
    Kadoi, C
    Matsumoto, M
    Hayasaka, Y
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1999, 25 (09): : 1286 - 1288
  • [8] TREATMENT OF GRAVES OPHTHALMOPATHY WITH HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE PULSE THERAPY
    NAGAYAMA, Y
    IZUMI, M
    KIRIYAMA, T
    YOKOYAMA, N
    MORITA, S
    KAKEZONO, F
    OHTAKARA, S
    MORIMOTO, I
    OKAMOTO, S
    NAGATAKI, S
    ACTA ENDOCRINOLOGICA, 1987, 116 (04): : 513 - 518
  • [9] High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behcet retinitis
    Reed, JB
    Morse, LS
    Schwab, IR
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 125 (03) : 409 - 411
  • [10] A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy
    Kemchoknatee, Parinee
    Tangon, Duanghathai
    Srisombut, Thansit
    BMC OPHTHALMOLOGY, 2023, 23 (01)